California 2021-2022 Regular Session

California Assembly Bill AR129 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 CALIFORNIA LEGISLATURE 20212022 REGULAR SESSION House Resolution No. 129Introduced by Assembly Member ValladaresAugust 11, 2022 Relative to Pancreatic Cancer Awareness Month.LEGISLATIVE COUNSEL'S DIGESTHR 129, as introduced, Valladares. Digest KeyBill TextWHEREAS, In 2022, an estimated 62,210 people will be diagnosed with pancreatic cancer and 49,830 people will die from the disease in the United States; andWHEREAS, Pancreatic cancer is one of the deadliest cancers, is the third leading cause of cancer death in the United States, and has a five-year relative survival rate of only 11 percent; andWHEREAS, Symptoms of pancreatic cancer usually first present themselves in its late stage. If detected at an early stage when surgical removal of a tumor is possible, the five-year survival rate is 42 percent, but only 13 percent of people are diagnosed at this stage. For 52 percent of pancreatic cancer patients where the cancer spreads to a distant part of the body, the five-year survival rate is 3 percent; andWHEREAS, The federal government invests significantly less money in pancreatic cancer research than it does in research of any other leading deadly cancer. In 2020, the National Cancer Institute (NCI) had a budget of $6,400,000,000. Of this, only $178,500,000 went towards pancreatic cancer research, which is just under 3 percent. This year, Congress provided $6,900,000,000 for the NCI, increasing their budget by $353,000,000 from the previous fiscal year; and WHEREAS, The Pancreatic Cancer Action Network (PanCAN) is a national organization that serves the pancreatic cancer community in its California headquarters. The organization is investing $25,000,000 in pancreatic cancer research this year. PanCAN received 15,000,000 from Congress in this years fiscal package; and WHEREAS, The good health and well-being of the residents of California are enhanced as a direct result of increased awareness about pancreatic cancer and research into early detection, causes, and effective treatments; now, therefore, be itResolved by the Assembly of the State of California, That the Assembly hereby recognizes that pancreatic cancer statistics call for aggressive measures now to develop early detection and treatment tools before the incidence dramatically increases, in light of the fact that NCI funding is falling dangerously behind; and be it furtherResolved, That the Assembly hereby proclaims November 2022 as Pancreatic Cancer Awareness Month in California and urges all California citizens to wage hope to end pancreatic cancer; and be it furtherResolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.
22
33 CALIFORNIA LEGISLATURE 20212022 REGULAR SESSION House Resolution No. 129Introduced by Assembly Member ValladaresAugust 11, 2022 Relative to Pancreatic Cancer Awareness Month.LEGISLATIVE COUNSEL'S DIGESTHR 129, as introduced, Valladares. Digest Key
44
55
66
77
88
99 CALIFORNIA LEGISLATURE 20212022 REGULAR SESSION
1010
1111 House Resolution
1212
1313 No. 129
1414
1515 Introduced by Assembly Member ValladaresAugust 11, 2022
1616
1717 Introduced by Assembly Member Valladares
1818 August 11, 2022
1919
2020 Relative to Pancreatic Cancer Awareness Month.
2121
2222 LEGISLATIVE COUNSEL'S DIGEST
2323
2424 ## LEGISLATIVE COUNSEL'S DIGEST
2525
2626 HR 129, as introduced, Valladares.
2727
2828
2929
3030 ## Digest Key
3131
3232 ## Bill Text
3333
3434 WHEREAS, In 2022, an estimated 62,210 people will be diagnosed with pancreatic cancer and 49,830 people will die from the disease in the United States; and
3535
3636 WHEREAS, Pancreatic cancer is one of the deadliest cancers, is the third leading cause of cancer death in the United States, and has a five-year relative survival rate of only 11 percent; and
3737
3838 WHEREAS, Symptoms of pancreatic cancer usually first present themselves in its late stage. If detected at an early stage when surgical removal of a tumor is possible, the five-year survival rate is 42 percent, but only 13 percent of people are diagnosed at this stage. For 52 percent of pancreatic cancer patients where the cancer spreads to a distant part of the body, the five-year survival rate is 3 percent; and
3939
4040 WHEREAS, The federal government invests significantly less money in pancreatic cancer research than it does in research of any other leading deadly cancer. In 2020, the National Cancer Institute (NCI) had a budget of $6,400,000,000. Of this, only $178,500,000 went towards pancreatic cancer research, which is just under 3 percent. This year, Congress provided $6,900,000,000 for the NCI, increasing their budget by $353,000,000 from the previous fiscal year; and
4141
4242 WHEREAS, The Pancreatic Cancer Action Network (PanCAN) is a national organization that serves the pancreatic cancer community in its California headquarters. The organization is investing $25,000,000 in pancreatic cancer research this year. PanCAN received 15,000,000 from Congress in this years fiscal package; and
4343
4444 WHEREAS, The good health and well-being of the residents of California are enhanced as a direct result of increased awareness about pancreatic cancer and research into early detection, causes, and effective treatments; now, therefore, be it
4545
4646 Resolved by the Assembly of the State of California, That the Assembly hereby recognizes that pancreatic cancer statistics call for aggressive measures now to develop early detection and treatment tools before the incidence dramatically increases, in light of the fact that NCI funding is falling dangerously behind; and be it further
4747
4848 Resolved, That the Assembly hereby proclaims November 2022 as Pancreatic Cancer Awareness Month in California and urges all California citizens to wage hope to end pancreatic cancer; and be it further
4949
5050 Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.